Recent epidemiological research show that AR antagonists delay the speed of useful decline as well as the incidence of AD pathogenesis (19, 20)
Recent epidemiological research show that AR antagonists delay the speed of useful decline as well as the incidence of AD pathogenesis (19, 20). of AMPA receptors with a system